NuvOx Pharma’s NVX-208 Shows Positive Results in Phase Ib/II Stroke Trial

Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference.  The trial was sponsored by the University of Arkansas for Medical Sciences. William “Bill” Culp, MD, the principal investigator on the trial, said, “Such strong safety and promising efficacy results meet our highest hopes for this small trial. Expanded trials are fully warranted.”Continue reading

Natural cancer killers: ASU Biodesign researcher enhances ability of immune system

Cancer remains a leading cause of death globally and is the focus of exhaustive and varied medical research. Many of Arizona State University’s Biodesign Institute researchers are working to establish alternative therapies that sidestep the harmful effects of chemotherapy and radiation while improving the success rate for the more difficult-to-treat cancers.Continue reading